Clinical Pharmacoepidemiology Training Grant

宾夕法尼亚大学医学院临床流行病学和生物统计学中心（CCEB） (SOM)与费城科学大学（USP）合作，提出开发一种创新的 临床药物流行病学研究培训计划，专门用于培训临床医生严谨， 独立的学术研究人员能够使用流行病学中的一系列方法来研究药物的使用， 药物对人群的影响。 培训计划的具体目标是：1）提供深入的研究技术知识 适合临床药物流行病学研究; 2）提供对临床药物流行病学基本原理的理解 药理学; 3）为临床药物流行病学相关主题的研究提供机会; 4）提供 与临床药物流行病学导师一起进行密集的监督研究经验;以及5）将教师聚集在一起 通过参加在CCEB和南太平洋大学举办的系列研讨会，为研究员和研究员提供培训。受训者将获得理学硕士学位， 临床流行病学（MSCE）学位，并有资格参加临床药理学委员会考试。 两年至三年的培训计划包括：1）临床流行病学必修课程的核心课程， 研究方法学和生物统计学; 2）药物流行病学和药代动力学必修课程; 3）要求 临床药理学的临床经验; 4）药理学，药学实践或其他领域的选修课程 与学员的兴趣和经验相关; 5）广泛的独立阅读; 6）由高级管理人员提供的指导 方法学家/临床药物流行病学家、临床药理学家和生物统计学家; 7）出席和 参加CCEB和南太平洋大学的研究研讨会;以及8）完成一项有指导的独立研究 临床药物流行病学项目。 拟议计划的优势是：1）CCEB成功的研究培训计划的悠久历史; 2） 为学员提供的全面课程和研究计划; 3）国际知名的 CCEB的临床药物流行病学计划; 4）杰出的药学培训计划 由USP提供;以及5）项目总监和教职员工的广泛成功培训记录。

The Center for Clinical Epidemiology and Biostatistics (CCEB) of the University of Pennsylvania School of Medicine (SOM), in collaboration with the University of the Sciences in Philadelphia (USP), proposes to develop an innovative research training program in clinical pharmacoepidemiology, specifically designed to train clinicians to be rigorous, independent academic investigators able to use the range of approaches available in epidemiology to study the use and effects of medications in populations. The specific aims of the training program are to: 1) provide in-depth knowledge of the research techniques appropriate to clinical pharmacoepidemiology research; 2) provide an understanding of the basic principles of clinical pharmacology; 3) provide opportunities for the study of topics related to clinical pharmacoepidemiology; 4) provide intensive, supervised research experience with mentors in clinical pharmacoepidemiology; and 5) bring together faculty and fellows through participation in seminar series in the CCEB and at USP. Trainees would earn a Master of Science in Clinical Epidemiology (MSCE) degree and be eligible to sit for the Clinical Pharmacology Board exam. The two- to three-year training program consists of: 1) a core curriculum of required courses in clinical epidemiology, research methodology, and biostatistics; 2) required courses in pharmacoepidemiology and pharmacokinetics; 3) required clinical experiences in clinical pharmacology; 4) elective courses in pharmacology, pharmacy practice, or other areas relevant to the trainees' interests and experience; 5) extensive independent readings; 6) mentoring provided by senior methodologists/clinjcal pharmacoepidemiologists, clinical pharmacologists, and biostatisticians; 7) attendance at and participation in research seminars in the CCEB and at USP; and 8) the completion of a mentored independent research project in clinical pharmacoepidemiology. Strengths of the proposed program are: 1) the long history of successful research training programs in the CCEB; 2) the comprehensive course offerings and research programs that are available to trainees; 3) the internationally renowned clinical pharmacoepidemiology program housed in the CCEB; 4) the distinguished pharmaceutical training program offered by USP; and 5) the extensive successful training records of the program director and faculty.